| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Mack RB |
A bit on the Wilde side: MDMA abuse |
N C Med J |
1985 |
| Ziporyn T |
A growing industry and menace: makeshift laboratory's designer drugs |
JAMA |
1986 |
| Beck J, Morgan PA |
Designer drug confusion: a focus on MDMA |
J Drug Educ |
1986 |
| Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
| Barnes DM |
Ecstasy returns to Schedule I |
Science |
1988 |
| Bost RO |
3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivat... |
J Forensic Sci |
1988 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Callahan PM, Appel JB |
Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... |
J Pharmacol Exp Ther |
1988 |
| Stanford MW |
Designer drugs: Medical aspects and clinical management |
Alcoholism Treatment... |
1988 |
| Schechter MD |
Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1989 |
| Beebe DK, Walley E |
Update on street drugs in Mississippi |
J Miss State Med Ass... |
1989 |
| Gold LH, Geyer MA, Koob G... |
Neurochemical mechanisms involved in behavioral effects of amphetamine... |
NIDA Res Monogr |
1989 |
| Insel TR, Battaglia G, Jo... |
3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... |
J Pharmacol Exp Ther |
1989 |
| Whitaker-Azmitia PM, Aron... |
'Ecstasy' (MDMA)-induced panic |
Am J Psychiatry |
1989 |
| Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
| Leikin JB, Krantz AJ, Zel... |
Clinical features and management of intoxication due to hallucinogenic... |
Med Toxicol Adverse ... |
1989 |
| Glennon RA, Misenheimer B |
Stimulus properties of a new designer drug: 4-methylaminorex ('U4Euh') |
Pharmacol Biochem Be... |
1990 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| Kosten TR |
Neurobiology of abused drugs. Opioids and stimulants |
J Nerv Ment Dis |
1990 |
| Beck J, Rosenbaum M |
The Scheduling of MDMA ('Ecstasy') |
Pursuit of Ecstasy |
1990 |
| Battaglia G, Sharkey J, K... |
Neuroanatomic specificity and time course of alterations in rat brain ... |
Synapse |
1991 |
| Garrett ER, Seyda K, Marr... |
High performance liquid chromatographic assays of the illicit designer... |
Acta Pharm Nord |
1991 |
| Glennon RA |
Phenylalkylamine stimulants, hallucinogens, and designer drugs |
NIDA Res Monogr |
1991 |
| Ruttenber AJ |
Stalking the elusive designer drugs: Techniques for monitoring new pro... |
Journal of Addictive... |
1991 |
| Glennon RA |
Discriminative Stimulus Properties of Hallucinogens and Related Design... |
NIDA Res Mon |
1991 |
| Randall T |
Ecstasy-Fueled 'Rave' Parties Become Dances of Death For English Youth... |
JAMA |
1992 |
| Preston A |
Pointing out the Risk |
Nursing Times |
1992 |
| Young R |
Aminorex produces stimulus effects similar to amphetamine and unlike t... |
Pharmacol Biochem Be... |
1992 |
| Sternbach GL, Varon J |
'Designer drugs'. Recognizing and managing their toxic effects |
Postgrad Med |
1992 |
| Thurman EM, Pedersen MJ, ... |
Distinguishing sympathomimetic amines from amphetamine and methampheta... |
J Anal Toxicol |
1992 |
| Wodarz N |
'Ecstasy'-induced psychotic depersonalization syndrome |
Nervenarzt |
1993 |
| Duxbury AJ |
Ecstasy--dental implications |
Br Dent J |
1993 |
| O'Neill D, Dart JK |
Methylenedioxyamphetamine ('Ecstasy') associated keratopathy |
Eye |
1993 |
| Emerson TS, Cisek JE |
Methcathinone: a Russian designer amphetamine infiltrates the rural mi... |
Ann Emerg Med |
1993 |
| Bronson ME, Jiang W, Clar... |
Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken |
Brain Res Bull |
1994 |
| Connor B |
Hazards associated with the recreational drug 'ecstasy' |
Br J Hosp Med |
1994 |
| House RV, Thomas PT, Bhar... |
Selective modulation of immune function resulting from in vitro exposu... |
Toxicology |
1995 |
| Bryden AA, Rothwell PJ, O... |
Urinary retention with misuse of 'ecstasy' |
BMJ |
1995 |
| Bronson ME, Wages TD, Bed... |
Morphine, MDMA, MDA, and nexus produce a conditioned place preference ... |
Exp Clin Psychopharm... |
1996 |
| Coore JR |
A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine... |
J R Soc Med |
1996 |
| Maurer HH |
On the metabolism and the toxicological analysis of methylenedioxyphen... |
Ther Drug Monit |
1996 |
| Ensslin HK, Kovar KA, Mau... |
Toxicological detection of the designer drug 3,4-methylenedioxyethylam... |
J Chromatogr B Biome... |
1996 |
| Schwartz RH, Miller NS |
MDMA (ecstasy) and the rave: a review |
Pediatrics |
1997 |
| Glennon RA, Young R, Duka... |
Initial characterization of PMMA as a discriminative stimulus |
Pharmacol Biochem Be... |
1997 |
| Kua EH |
Designer Drugs--the Ecstasy and the Agony |
Singapore Med J |
1997 |
| Tsatsakis AM, Michalodimi... |
MDEA related death in Crete: a case report and literature review |
Vet Hum Toxicol |
1997 |
| Dal Cason TA |
The characterization of some 3,4-methylenedioxycathinone MDCATH homolo... |
Forensic Science Int... |
1997 |
| Keller T, Miki A, Regensc... |
Detection of designer drugs in human hair by ion mobility spectrometry... |
Forensic Sci Int |
1998 |
| Byard RW, Gilbert J, Jame... |
Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the... |
Am J Forensic Med Pa... |
1998 |
| Plessinger MA |
Prenatal exposure to amphetamines. Risks and adverse outcomes in pregn... |
Obstet Gynecol Clin ... |
1998 |
| Young R, Glennon RA |
Discriminative stimulus properties of (-)ephedrine |
Pharmacol Biochem Be... |
1998 |
| Metzger RR, Hanson GR, Gi... |
3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine tr... |
Eur J Pharmacol |
1998 |
| Wollina U, Kammler HJ, He... |
Ecstasy pimples - a new facial dermatosis |
Dermatology |
1998 |
| Ramcharan S, Meenhorst PL... |
Survival after massive ecstasy overdose |
J Toxicol Clin Toxic... |
1998 |
| Schwab M, Seyringer E, Br... |
Fatal MDMA intoxication |
Lancet |
1999 |
| Ramseier A, Caslavska J, ... |
Stereoselective screening for and confirmation of urinary enantiomers ... |
Electrophoresis |
1999 |
| Rochester JA, Kirchner JT |
Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, ... |
J Am Board Fam Pract |
1999 |
| Appel JB, West WB, Roland... |
Increasing the selectivity of drug discrimination procedures |
Pharmacol Biochem Be... |
1999 |
| Young R, Dukat M, Malmusi... |
Stimulus properties of PMMA: effect of optical isomers and conformatio... |
Pharmacol Biochem Be... |
1999 |
| de Boer D, Egberts T, Mae... |
Para-methylthioamphetamine, a new amphetamine designer drug of abuse |
Pharm World Sci |
1999 |
| Glennon RA |
Arylalkylamine drugs of abuse: an overview of drug discrimination stud... |
Pharmacol Biochem Be... |
1999 |
| Kreth KP,Kovar KA, Schwab... |
Identification of the Human Cytochromes P450 Involved in the Oxidative... |
Biochem Pharmacol |
2000 |
| Maurer HH, Bickeboeller-F... |
Toxicokinetics and analytical toxicology of amphetamine-derived design... |
Toxicol Lett |
2000 |
| Bogusz MJ, Kruger KD, Mai... |
Analysis of underivatized amphetamines and related phenethylamines wit... |
J Anal Toxicol |
2000 |
| Christophersen AS |
Amphetamine designer drugs - an overview and epidemiology |
Toxicol Lett |
2000 |
| Morland J |
Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental e... |
Toxicol Lett |
2000 |
| Ramseier A, Siethoff C, C... |
Confirmation testing of amphetamines and designer drugs in human urine... |
Electrophoresis |
2000 |
| Clauwaert KM, Van Bocxlae... |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... |
Clin Chem |
2000 |
| Gomez-Balaguer M, Pena H,... |
Syndrome of Inappropriate Antidiuretic Hormone Secretion and 'Designer... |
Journal of Pediatric... |
2000 |
| Pepin G, Cheze M, Billaul... |
New hallucinogenic in Europe: Ayahuasca or the Vine of the Spirit |
Journal of Forensic ... |
2000 |
| Borth S, Hänsel W, Rösner... |
Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their re... |
Forensic Sci Int |
2000 |
| Clauwaert KM, Van Bocxlae... |
Determination of the designer drugs 3, 4-methylenedioxymethamphetamine... |
Clin Chem |
2000 |
| Anderson C |
Water intake probed in death |
Boulder Daily Camera |
2001 |
| Zhao H, Brenneisen R, Sch... |
Profiles of urine samples taken from Ecstasy users at Rave parties: an... |
J Anal Toxicol |
2001 |
| Hong SS |
Discriminative stimulus properties of alpha-ethyltryptamine optical is... |
Pharmacol Biochem Be... |
2001 |
| De Letter EA, Coopman VA,... |
One fatal and seven non-fatal cases of 4-methylthioamphetamine 4-MTA i... |
Int J Legal Med |
2001 |
| de Boer D, Bosman IJ, Hid... |
Piperazine-like compounds: a new group of designer drugs-of-abuse on t... |
Forensic Sci Int |
2001 |
| Hong SS, Young R, Glennon... |
Discriminative stimulus properties of alpha-ethyltryptamine optical is... |
Pharmacol Biochem Be... |
2001 |
| Clauwaert KM, Van Bocxlae... |
Stability study of the designer drugs 'MDA, MDMA and MDEA' in water, s... |
Forensic Sci Int |
2001 |
| Kraemer T, Maurer HH |
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... |
Ther Drug Monit |
2002 |
| von Sydow K, Lieb R, Pfis... |
Use, abuse and dependence of ecstasy and related drugs in adolescents ... |
Drug and Alcohol Dep... |
2002 |
| Glennon RA, Young R, Rang... |
Further characterization of the stimulus properties of 5,6,7,8- tetrah... |
Pharmacol Biochem Be... |
2002 |
| Pellegrini M, Rosati F, P... |
Rapid screening method for determination of Ecstasy and amphetamines i... |
J Chromatogr B Analy... |
2002 |
| Hess D, DeBoer S |
Ecstasy: This designer drug is increasing in popularity and may be com... |
Am J Nurs |
2002 |
| Wax PM |
Just a Click Away: Recreational Drug Web Sites on the Internet |
Pediatrics |
2002 |
| Meyer A, Mayerhofer A, Ko... |
Enantioselective metabolism of the designer drugs 3,4-methylenedioxyme... |
Neurosci Lett |
2002 |
| Simonsen KW, Kaa E, Niels... |
Narcotics at street level in Denmark. A prospective investigation from... |
Forensic Sci Int |
2003 |
| De Letter EA, Espeel MF, ... |
Immunohistochemical demonstration of the amphetamine derivatives 3,4-m... |
Int J Legal Med |
2003 |
| Peters FT, Schaefer S, St... |
Screening for and validated quantification of amphetamines and of amph... |
J Mass Spectrom |
2003 |
| Dams R, De Letter EA, Mor... |
Fatality due to combined use of the designer drugs MDMA and PMA: a dis... |
J Anal Toxicol |
2003 |
| Staack RF, Fritschi G, Ma... |
New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas ... |
J Mass Spectrom |
2003 |
| Turner C, Russell A, Brow... |
Prevalence of illicit drug use in young Australian women, patterns of ... |
Addiction |
2003 |
| Carvalho M, Milhazes N, R... |
Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopami... |
Arch Toxicol |
2003 |
| Carmo H, Hengstler JG, de... |
Comparative metabolism of the designer drug 4-methylthioamphetamine by... |
Naunyn Schmiedebergs... |
2004 |
| Staack RF, Theobald DS, P... |
In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperaz... |
Xenobiotica |
2004 |
| Maurer HH, Kraemer T, Spr... |
Chemistry, pharmacology, toxicology, and hepatic metabolism of designe... |
Ther Drug Monit |
2004 |
| de la Torre R, Farre; M, ... |
Clinical pharmacokinetics of amfetamine [amphetamine] and related subs... |
Clin Pharmacokinet |
2004 |
| Vorce SP, Sklerov JH |
A general screening and confirmation approach to the analysis of desig... |
J Anal Toxicol |
2004 |
